| 1 |
34382727 | miR-221 confers lapatinib resistance by negatively regulating p27kip1 in HER2-positive breast cancer. | 2021 Oct |
4 |
| 2 |
28158234 | Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. | 2017 |
1 |
| 3 |
26621843 | The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cells. | 2016 Jan 19 |
1 |
| 4 |
26643609 | Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer. | 2016 Feb |
1 |
| 5 |
27756261 | Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways. | 2016 Oct 19 |
1 |
| 6 |
25865888 | Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains. | 2015 Apr 21 |
1 |
| 7 |
24200972 | Src and CXCR4 are involved in the invasiveness of breast cancer cells with acquired resistance to lapatinib. | 2014 |
5 |
| 8 |
24887236 | Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models. | 2014 May 5 |
10 |
| 9 |
25350844 | Src mutation induces acquired lapatinib resistance in ERBB2-amplified human gastroesophageal adenocarcinoma models. | 2014 |
3 |
| 10 |
23913825 | SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases. | 2013 Sep 15 |
1 |
| 11 |
22389470 | HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancer. | 2012 Apr |
1 |
| 12 |
21499296 | Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. | 2011 Oct 6 |
2 |